Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 2,510.00
-440.00 (-14.92%)
At close: May 8, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 9.75 billion as of May 11, 2026. Its market cap has decreased by -36.18% in one year.
Market Cap
9.75B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
8.28
Stock Price
2,510.00
Market Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 9.75B, a decrease of -58.64%. That is a compound annual growth rate of -29.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 8.98B | -29.49% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baskhanbio Pharma | 35.06B |
| Seoul Pharma | 31.77B |
| Pharmsville | 27.51B |
| ChoA Pharmaceutical Co., LTD. | 27.42B |
| Daesung Microbiological Labs. | 25.73B |
| Hurum | 25.44B |
| BIFIDO | 23.35B |
| Union Korea Pharm | 19.70B |